JAAD-D-20-02928 Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety

Published: 23 November 2020| Version 1 | DOI: 10.17632/ytywtbdjb3.1
Contributors:
Zoe Apalla,
Aimilios Lallas

Description

The file contains detailed data from the study entitled "Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety" that has been accepted for publication in JAAD. The authors contributing in this study and their corresponding affiliations are as follows: Authors list: Zoe Apalla, PhD1, Ioannis Spyridis MD2, Athanassios Kyrgidis, PhD3, Elizabeth Lazaridou, PhD1, Aikaterini Kyriakou, PhD1, Christina Fotiadou, PhD1, Olga Pikou, MD1, Elena Sotiriou, PhD1, Efstratios Vakirlis, PhD2, Chryssoula Papageorgiou, PhD2, Florentina Delli, MD4, Andreas Moutsoudis, MD2, Sofia Magdalini Manoli, MD2, Dimitrios Ioannides, PhD2, Aimilios Lallas, PhD2. Affiliations 1. Second Dermatology Department, Aristotle University of Thessaloniki, Greece 2. First Dermatology Department, Aristotle University of Thessaloniki, Greece 3. Clinical Pharmacology Department, Medical School, Aristotle University of Thessaloniki, Greece 4. State Dermatology Department, Hippokratio General Hospital of Thessaloniki, Greece

Files

Institutions

Aristotle University of Thessaloniki

Categories

Dermatology, Skin Cancer, Vismodegib, Non-Melanoma Skin Cancer

License